BioAge Labs, Inc. (BIOA)

BioAge Labs Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Mar 9, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Market Cap	824	198	-	-
Market Cap Growth	422.26%	-	-	-
Enterprise Value	524.2	-153.85	0	0
Last Close Price	19.73	5.79	-	-
PE Ratio	-	-0.87	-	-
PB Ratio	2.62	0.61	-	-
P/TBV Ratio	2.55	0.19	-	-
P/FCF Ratio	-	-3.82	-	-
P/OCF Ratio	-	-3.84	-	-
EV/EBITDA Ratio	-	1.97	-	-
EV/EBIT Ratio	-	1.97	-	-
EV/FCF Ratio	-	2.96	-	-
Debt / Equity Ratio	0.01	0.01	-0.71	0.11
Debt / EBITDA Ratio	-0.08	-0.11	-0.73	-0.06
Debt / FCF Ratio	-0.12	-0.17	-0.93	-0.07
Net Debt / Equity Ratio	-1.00	-1.07	-0.06	0.22
Net Debt / EBITDA Ratio	3.11	4.43	-0.21	0.63
Net Debt / FCF Ratio	4.71	6.66	-0.27	0.69
Quick Ratio	11.69	12.76	0.43	4.72
Current Ratio	11.87	12.86	0.44	4.78
Return on Equity (ROE)	-25.24%	-50.35%	622.63%	-197.00%
Return on Assets (ROA)	-27.05%	-40.71%	-178.10%	-140.59%
Return on Invested Capital (ROIC)	6338.33%	836.34%	706.72%	822.41%
Return on Capital Employed (ROCE)	-29.37%	-52.44%	1000.41%	-177.10%
Earnings Yield	-9.32%	-114.51%	-	-
FCF Yield	-7.28%	-26.21%	-	-
Buyback Yield / Dilution	-13.11%	-112.25%	-	-

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q